No Data
No Data
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?
Rodman & Renshaw Downgrades Biomea Fusion(BMEA.US) to Hold Rating, Cuts Target Price to $9
Rodman & Renshaw analyst Anthony Butler downgrades $Biomea Fusion(BMEA.US)$ to a hold rating, and adjusts the target price from $32 to $9.According to TipRanks data, the analyst has a success rate of
H.C. Wainwright Maintains Biomea Fusion(BMEA.US) With Buy Rating, Cuts Target Price to $15
H.C. Wainwright analyst Joseph Pantginis maintains $Biomea Fusion(BMEA.US)$ with a buy rating, and adjusts the target price from $50 to $15.According to TipRanks data, the analyst has a success rate o
Express News | HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $15 Price Target
Biomea Fusion, Inc. (BMEA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Biomea Fusion Stock Down 48% But Insiders Still In US$17k Profit
Biomea Fusion, Inc. (NASDAQ:BMEA) insiders who acquired shares over the previous 12 months, can probably afford to ignore the recent 48% decline in the stock price. After taking the recent loss into